Cambridge firm wins national Business Innovation category at 2018 SME National Business Awards
- Intelligent Fingerprinting secures national recognition in UK following the success of its revolutionary fingerprint-based drug testing system
Cambridge-based Intelligent Fingerprinting, developer of the world’s first fingerprint-based drug test, has won the prestigious Clydesdale Bank Business Innovation category at the SME National Business Awards 2018. The win was announced on Friday 7th December at Wembley Stadium, London, England and recognizes the company’s achievement in developing and bringing to market its revolutionary portable fingerprint-based drug testing solution for use at the point-of-care. The system is currently available for forensic use only in the USA.
This major national award follows on from Intelligent Fingerprinting’s success earlier this year when it secured the 2018 Business Innovation and Overall SME Cambridgeshire Business categories at a local awards ceremony held at Newmarket Racecourse in June. Winning there resulted in an automatic shortlisting for the SME National Business Awards, with Intelligent Fingerprinting competing against 13 other category national finalists from a range of sectors including IT, Electronics, Engineering, Healthcare, Logistics, Media and Services. Intelligent Fingerprinting’s SME National Business Awards submission detailed how its non-invasive drug test works by analyzing sweat from a fingerprint to determine if someone has recently used cocaine, opiates, amphetamines or cannabis.
“We’re absolutely delighted to have won the Business Innovation prize at this year’s SME National Business Awards. It highlights our company’s ability not just to introduce a revolutionary drug detection technology, but also to ensure that our solution is fully developed and manufactured to meet today’s growing market requirement for non-invasive drug tests,” commented Intelligent Fingerprinting’s CEO Jerry Walker. “We were also proud to be representing Cambridgeshire at the SME National Business Awards final. Cambridge is proving a great place for an innovative medical device diagnostics company such as Intelligent Fingerprinting to grow its business, and we look forward to building on this success as we focus on extending our company’s sales drive to support employers, coroners, drug treatment services and offender management operations in 2019.”
Fingerprint-based drug testing – how it works
Intelligent Fingerprinting’s end-to-end drug testing solution features a small, single-use drug screening cartridge which takes just five seconds to collect a fingerprint sweat sample. The Intelligent Fingerprinting portable analysis unit then reads the cartridge and provides a positive or negative result on-screen for cocaine, opiates, cannabis, and amphetamines in ten minutes.
Should an employee’s initial screening test prove positive for any of the four drugs tested – in contravention of a firm’s drug and alcohol policy – two further sets of fingerprint samples are gathered for confirmation testing using the Intelligent Fingerprinting Fingerprint Collection Kit for Laboratory Analysis. Informed written consent is obtained from the donor prior to sample collection, along with a statement of the donor’s prescription medication, if applicable.
Once confirmation samples have been collected, the Fingerprint Collection Cartridges are sent to Intelligent Fingerprinting’s partner laboratory for analysis. The laboratory provides the customer with a quantitative laboratory result in the form of a Certificate of Analysis.
Importantly, as a first in its class, all the company’s single-use cartridges can be recycled.
An introductory video demonstrating fingerprint-based drug testing in action is available here.
For media information contact Cheryl Billson at Comma
Email: email@example.com Tel: +44 (0)7791 720460
About Intelligent Fingerprinting
Launched in 2017, Intelligent Fingerprinting’s portable Drug Screening System works by analyzing the sweat from a fingerprint sample. It is non-invasive, fast and cost-effective – screening for multiple drug groups simultaneously (currently amphetamines, cannabis, cocaine, and opiates) with sample collection taking 5 seconds and results in minutes.
In the UK, the system is currently being marketed to the criminal justice arena, drug rehabilitation services, offender management, workplace, and occupational health services. The technique has potential for many other uses including healthcare diagnostics and homeland security applications. The system is currently available for forensic use only in the USA.
Founded in 2007, Intelligent Fingerprinting is a spin-out company from the University of East Anglia (UEA). The company is based in Cambridge, England and currently employs around 30 people. www.intelligentfingerprinting.com Twitter @iFingerprinting